Abstract
Background:
Takayasu arteritis (TAK) is a rare large-vessel vasculitis that affects the carotid arteries. Increased intima–media thickness (IMT) and atherosclerotic changes are detectable by ultrasonography (US). This study aimed to evaluate detailed carotid sonographic features in TAK and compare them with diabetes mellitus (DM), as well as to assess correlations between sonographic parameters and inflammatory markers.
Methods:
In this case-control study, 15 patients with TAK fulfilling the 1990 American College of Rheumatology criteria (2012–2022) and 15 patients with DM were evaluated at Loghman Hakim Hospital. Cardiovascular risk factors, carotid ultrasonography, and serum inflammatory markers were assessed. Data were analyzed using univariate and multiple regression tests (SPSS V24).
Results:
Atherosclerotic plaques were found in 46.7% of TAK and 53.3% of DM patients. IMT of common (CCA) and internal carotid arteries (ICA) was significantly higher in TAK (p<0.05). The macaroni sign (P=0.001), turbulent flow (P=0.006), and higher CCA resistivity index (RI) (P=0.047) were characteristic of TAK. ESR and CRP correlated with pre-bifurcation CCA mean IMT (p<0.05). Each unit increase in CRP was associated with a 0.02 mm increase in right CCA IMT (P=0.05).
Conclusion:
Carotid ultrasonography is a valuable tool in evaluating TAK. Distinguishing features include the presence of the macaroni sign, turbulent flow, and higher IMT and RI. Increased IMT was associated with elevated CRP.
Key Words: Vasculitis, Takayasu’s arteritis, Atherosclerosis, Ultrasonography, Diabetes mellitus
Takayasu arteritis (TAK) is a rare an inflammatory disease typically presenting in women before the age of 40 , that affects mostly subclavian and carotid arteries (1, 2). Stenotic or occlusive lesions occur in >90% and may be associated with limb claudication, and cerebral ischemia (2). Advanced lesions demonstrate panarteritis with intimal proliferation (3). Moreover, atherosclerosis is an inflammatory-immunological-degenerative process (4), that increases in TAK because of the intense vascular inflammation. Vascular stiffness and arterial resistance increase in TAK; also, atherosclerosis leads to similar changes (1). The carotid arteries can easily be depicted by ultrasonography (US). Generalized atherosclerosis such as atherosclerotic plaques and the measurement of intima–media thickness (IMT) can evaluate by US (5). Differential diagnoses between Takayasu and atherosclerosis in practice may be not easy for clinicians. We think that vascular changes of TAK are distinguishable from atherosclerosis when evaluated with US. In addition, we know that no specific biomarker describes these changes. ESR as an inflammatory biomarker has a low specificity and sensitivity for disease activity in TAK (6). Moreover fibrinogen, as an inflammatory marker, is correlated with subclinical CVD (7) but has not been assessed in TAK.
Also, few studies showed the association between CRP and IMT in TAK and RA (rheumatoid arthritis) (8, 9). Our study aimed to evaluate sonographic features of TAK, atherosclerosis prevalence and measurement of carotid artery IMT in TAK and patients with diabetes. Finally, we compared vascular ultrasonography parameters with the serum level of the inflammatory biomarker such as ESR, CRP and fibrinogen.
Methods
Patients and physical examination:
In this case-control study, all patients with Takayasu's arteritis who had visited the Rheumatology Clinic of Loghman Hakim Hospital and Imam Hossein Hospital between 2012-2022 to perform this study were called. Fifteen patients with TAK (12 women, 3 men) aged 15 to 53 that met the criteria of the American College of Rheumatology (3) were enrolled. A diagnosis of Takayasu arteritis requires that at least 3 of the 6 criteria are met: age at disease onset less than 40 years, claudication of extremities, decreased brachial artery pulse, blood pressure difference more than 10 mm Hg, bruit over subclavian arteries or aorta, arteriogram abnormality. Patients with diabetes mellitus type 2 who were usually followed-up in the diabetes clinic were examined consecutively as a control group. We assessed risk factors for cardiovascular diseases included arterial hypertension, hypercholesterolemia, smoking, diabetes, obesity (4) and past history of stroke or myocardial infarction. The pulse difference in the upper limbs and carotid, subclavian, and kidney arteries bruit sound were investigated.
Laboratory measurement:
Blood samples were collected after overnight fasting. Biochemical parameters, including CBC, ESR, CRP, Fibrinogen, FBS, cholesterol, LDL, HDL, Bun, Cr, AST, ALT, ALKP and fibrinogen levels were measured by commercial laboratory diagnostic kits.
History, physical exam, laboratory test and sonographic evaluation were done in one day.
Sonography assessments:
Color Doppler US evaluation of carotid arteries was performed by an expert radiologist with 10 years’ experience in neuroradiology using Toshiba Aplio300 ultrasound machine linear transducer (PLT-704SBT 4.8-11 MHz). Intima media thickness (IMT) was measured in the far wall of CCA 1-cm proximal to bulb and in ICA 1-cm distal to bifurcation in both right and left sides. An IMT < 0.7 mm considered as normal and 0.7 mm < IMT > 1.5 mm interpreted as a thickened Intima Media. Also, IMT > 1.5 mm was considered as a plaque and the ratio of stenosis was calculated by NASCET criteria (8). The presence of turbulent flow in CCA and ICA due to stenosis is defined by color Doppler map. Also, resistivity index (RI) was calculated in both CCAs in TAK patients and diabetes. Macaroni sign is defined as a long homogeneous circumferential wall thickening in both CCAs which is a pathognomonic sign for Takayasu arteritis in the US reported (9).
Statistical analysis:
The numerical and categorical variables were expressed as mean ± standard deviation and frequency/percentage, respectively. The Kolmogorov-Smirnov test was used to assess variable normal distribution. Independent sample t-test was used for quantitative variables and chi-square and Fisher’s exact test was used for qualitative variables. U Mann-Whitney was used for variables that did not have a normal distribution (FBS, Fibrinogen, AST, and ALT). Pearson correlation and multiple linear regression models were done for evaluation association between sonographic findings with inflammatory index (CRP, fibrinogen) and demographic information. Multiple logistic regression analysis was conducted to compare risk factors between TAK and DM patients. A p-value below 0.05 was considered statistically significant in all analyses. The analysis was performed using a statistical package for the social sciences (SPSS, Version 24).
Results
In this study, 15 patients with TAK (80% women and 20% men with a mean age of 35.20±8.85 years) and 15 patients with DM (66.7% women and 33.3% men with a mean age of 51.13±8.47 years) were enrolled. We decided to evaluate atherosclerosis, so we had not considered a matched age set for the DM group study, and, they were older than patients with TAK. Two patients with TAK had DM simultaneously. Clinical information and traditional risk factors of atherosclerosis are shown in table 1. Patients with DM had higher BMI (28.34±5.40, P=0.036) and more HTN on physical exam (5 (33.3%), P=0.042).
Table1.
Clinical information, traditional risk factors of atherosclerosis and cardiovascular risk in TAK and DM groups
| P-value | DM (n=15) | TAK (n=15) | Variables |
|---|---|---|---|
| <0.001 | 51.13±8.47 | 35.20±8.85 | Age |
| Sex | |||
| 0.682 | 5 (33.3%) 10 (66.7%) |
3 (20%) 12 (80%) |
Male
Female |
| 0.036 | 28.34±5.40 | 24.41±4.36 | BMI |
| 0.896 | 7.47±5.53 | 7.73±5.56 | Disease onset |
| CVD n (%) | |||
| 0.169 | 1 (6.7%) 14 (93.3%) |
5 (33.3%) 10 (66.7%) |
Yes
No |
| IHD n (%) | |||
| >0.99 | 1 (6.7%) 14 (93.3%) |
2 (13.3%) 13 (86.7%) |
Yes
No |
| Stroke n (%) | |||
| 0.224 | 0 15 (100%) |
3 (20%) 12 (80%) |
Yes
No |
| DM n (%) | |||
| <0.001 | 15 (100%) 0 |
2 (13.3%) 13 (86.7%) |
Yes
No |
| Smoking n (%) | |||
| >0.99 | 2 (13.3%) 13 (86.7%) |
2 (13.3%) 13 (86.7%) |
Yes
No |
| History of HTN n (%) | |||
| 0.256 | 7 (46.7%) 8 (53.3%) |
4 (26.7%) 11 (73.3%) |
Yes
No |
| Pulse discrepancy n (%) | |||
| <0.001 | 0 15 (100%) |
14 (93.3%) 1 (6.7%) |
Yes
No |
| HTN on physical exam n (%) | |||
| 0.042 | 5 (33.3%) 10 (66.7%) |
0 15 (100%) |
Yes
No |
| Bruit (Totally: Carotid or Subclavian or Abdominal) n (%) | |||
| 0.042 | 0 15 |
8 (53.3%) 7 (46.7%) |
Yes
No |
| Carotid Bruit n (%) | |||
| 0.042 | 0 15 |
5 (33.3%) 10 (66.7%) |
Yes
No |
| Subclavian Bruit n (%) | |||
| 0.006 | 0 14 (93.3%) |
7 (46.7%) 8 (53.3%) |
Yes
No |
| Abdominal Bruit n (%) | |||
| 0.483 | 0 15 |
2 (13.3%) 13 (86.7%) |
Yes
No |
TAK: Takayasu’s arteritis, DM: Diabetes mellitus, n: number, BMI: Body mass index, CVD: Cardiovascular disease, IHD: Ischemic heart disease, HTN: Hypertension.
Pulse discrepancy and bruit of arteries (8 (53.3%), P=0.042) observed only in patients with TAK Prednisone was used by 13 patients with TAK (86.7%). Immunosuppressive drugs were used by 12 patients (80%) (Methotrexate by 2, azathioprine 5, infliximab by 4, adalimumab by 1, mycophenolate by 3). The use of statin, antiplatelet and hypertensive drugs was not significantly different in TAK and DM (p>0.05). Laboratory measurements of metabolic and inflammatory biomarkers are shown in table 2. Although the serum level of ESR, CRP and fibrinogen was higher in patients with TAK than in DM, the difference was not statistically significant (p>0.05). WBC and platelet amounts (8.90±2.56, 325.13±118.57) were higher (P=0.039, P=0.042) and hemoglobulin was lower in the TAK group (12±1.90, P=0.043). In the DM group, a significant increase of metabolic parameters including FBS, cholesterol, LDL, triglyceride, AST, ALT, ALKP and less Cr levels showed (p<0.05) (table 2).
Table 2.
Laboratory measurement in TAK and DM groups
| P-value | DM (n=15) | TAK (n=15) | |
| 0.039 | 7.30±1.26 | 8.90±2.56 | WBC |
| 0.043 | 13.30±1.40 | 12±1.90 | Hb |
| 0.042 | 253.20±45.79 | 325.13±118.57 | Platelet |
| 0.278 | 22.07±13.14 | 32±31.84 | ESR |
| 0.192 | 7.38±8.74 | 15.09±20.16 | CRP |
| 0.001 | 197.60±82.36 | 120.93±79.44 | FBS |
| 0.036 | 196.47±53.62 | 161.80±26.83 | Cholesterol |
| 0.138 | 108.60±44.62 | 88.60±23.20 | LDL |
| 0.862 | 50.87±20.60 | 49.80±11.48 | HDL |
| 0.010 | 231.47±146.00 | 114.53±61.31 | TG |
| 0.066 | 37.67±14.15 | 29.87±7.00 | Urea |
| 0.012 | 1.01±0.21 | 0.85±0.11 | Cr |
| 0.707 | 361.40±73.70 | 391.60±17.16 | Fibrinogen |
| 0.022 | 22.07±7.11 | 18.47±7.60 | AST |
| 0.084 | 23.53±16.94 | 18.93±12.60 | ALT |
| 0.029 | 222.07±78.67 | 156.67±74.08 | ALP |
WBC, White Blood Cell, Hb, Hemoglobin; AST, Aspartate Aminotransferase; ALT, Alanine Transaminase; Cr, Creatinine; ESR: Erythrocyte Sedimentation Rate; CRP: C-Reactive Protein.
Sonographic findings of carotid of two groups are shown in table 3. Complete occlusion of CCA was seen in 3 (20%) patients, and this finding was seen only in the TAK group. Atherosclerotic plaque was seen in 7 (46.7%) patients with TAK and 8 (53.3%) patients with DM and no significant difference was detected between two groups. IMT was more in CCAs and ICAs in patients with TAK than DM.
Table 3.
Carotid sonographic findings in TAK and DM groups
| P-Value | DM (n=15) | TAK (n=15) | |
|---|---|---|---|
|
Complete Occlusion totally
(Right and left) n (%) |
|||
| 0.224 | 0 15 |
3 (20%) 12 (80%) |
Yes
No |
| Complete Occlusion of Rt CCA n (%) | |||
| >0.99 | 0 15 |
1 (6.7%) 14 (93.3%) |
Yes
No |
| Complete Occlusion of Lt CCA n (%) | |||
| 0.483 | 0 15 |
2 (13.3%) 13 (86.7%) |
Yes
No |
| 0.005 | 0.60±0.13 | 1.35±0.87 | Before bifurcation Rt CCA IMT |
| 0.028 | 0.55±0.13 | 0.92±0.57 | After bifurcation Rt ICA IMT |
| 0.015 | 0.63±0.17 | 1.41±0.98 | Before bifurcation Lt CCA IMT |
| 0.153 | 0.53±0.11 | 0.72±0.43 | After bifurcation Lt ICA IMT |
| Turbulent flow Totally n (%) | |||
| 0.006 | 0 15 0 |
7 (46.7%) 8 (53.3%) 0 |
Yes
No No flow |
| Turbulent flow in Rt CCA n (%) | |||
| 0.017 | 0 15 0 |
5 (33.3%) 9 (60%) 1 (6.7%) |
Yes
No No flow |
| Turbulent flow in Lt CCA n (%) | |||
| 0.006 | 0 15 0 |
6 (40%) 8 (53.3%) 1 (6.7%) |
Yes
No No flow |
| Macaroni Sign totally (Rt and Lt) n (%) | |||
| 0.001 | 0 15 |
9 (60%) 6 (40%) |
Yes
No |
| Macaroni Sign Rt n (%) | |||
| 0.002 | 0 15 |
8 (53.3%) 7 (46.7%) |
Yes
No |
| Macaroni Sign Lt n (%) | |||
| 0.002 | 0 15 |
8 (53.3%) 7 (46.7%) |
Yes
No |
| Atherosclerotic Plaque n (%) | |||
| 0.715 | 8 (53.3%) 7 (46.7%) |
7 (46.7%) 8 (53.3%) |
Yes
No |
| 0.212 | 0.71±0.07 | 0.76±0.14 | Rt CCA RI |
| 0.047 | 0.68±0.06 | 0.79±0.17 | Lt CCA RI |
TAK: Takayasu’s arteritis, DM: Diabetes mellitus, n: number, IMT: intima–media thickness, Rt: Right, Lt: Left, CCA: Common carotid artery, ICA: Internal carotid artery, RI: Reversibility index.
Before bifurcation right CCA mean IMT (P=0.005), after bifurcation right ICA mean IMT (P=0.028), and before bifurcation left CCA mean IMT (P=0.015) was statistically significant higher in TAK group. Macaroni Sign (P=0.001) and turbulent flow (P=0.006) are depicted only in TAK group. Left CCA RI was higher in TAK group (P=0.047). The relationship between the atherosclerotic plaque with other sonographic findings showed a nonsignificant correlation with macaroni sign (P=0.059) and turbulent flow (P=0.054). Additional analysis showed the correlation of CRP and before bifurcation right CCA mean IMT (P= 0.051) also, correlation of ESR (P= 0.017) and CRP (P= 0.011) with before bifurcation left CCA mean IMT. Pearson correlation analysis results showed a correlation between ESR with CRP (p<0.001, with a coefficient correlation of 0.920 but no correlation between fibrinogen and ESR, or CRP was detected. Table 4 show associated risk factors for odds of TAK compared to DM in the multiple logistic regression model. After adjusting for potential important confounders, age and BMI were significantly associated with occurrence of TAK compared to DM. In other words, odds of developing TAK significantly decrease with age compared to DM (OR = 0.77, 95% CI = 0.62‑0.94).
Table 4.
Comparison of the risk factors between TAK and DM patients in the multiple logistic regression model
| P-value |
95%
Confidence Interval (CI) |
Odds Ratio (OR) | DM (n=15) | TAK (n=15) | Variables |
|---|---|---|---|---|---|
| 0.01 | 0.62-0.94 | 0.77 | 51.13±8.47 | 35.20±8.85 | Age |
| 0.07 | 0.49-1.03 | 0.71 | 28.34±5.40 | 24.41±4.36 | BMI |
| 0.31 | 0.03-6.40 - |
0.13 1 (Ref) |
1 (6.7%) 14 (93.3%) |
5 (33.3%) 10 (66.7%) |
CVD
Yes No |
| History of HTN | |||||
| 0.25 | 0.03-11.15 - |
0.55 1 (Ref) |
7 (46.7%) 8 (53.3%) |
4 (26.7%) 11 (73.3%) |
Yes
No |
| 0.67 | 0.74-1.21 | 0.94 | 7.38±8.74 | 15.09±20.16 | CRP |
| 0.40 | 0.91-1.24 | 1.06 | 22.07±13.14 | 32±31.84 | ESR |
BMI: Body mass index, CVD: cardiovascular disease, HTN: hypertension, CRP: C-reactive protein, ESR: Erythrocyte Sedimentation Rate
The same was true for BMI, but the reduction in odds of TAK compared to DM with increasing BMI was borderline significant (OR = 0.71, 95% CI = 0.49‑1.03). High rate of ESR was associated with TAK, with a 5% increased odds of TAK. However, it was not statistically significant. It seems that the small sample size of the study can justify these borderline findings. Other variables of CVDs and inflammatory biomarkers were not significantly different between the two groups in the multivariable model. Additionally, the relationship between sonographic findings with inflammatory markers, study groups, age, and underlying diseases was examined in multiple linear regression models. Findings showed that, for each unit increase in CPR, the value of before bifurcation right CCA mean IMT increases by 0.02 and this increase was statistically significant after adjusting for age, CVD, and HTN (β±S.E= 0.02±0.009, p=0.05). Also, TAK patients had an average of 0.6 more before bifurcation right CCA mean IMT than DM patients (β±S.E= 0.60±0.31, P=0.07) which was borderline significant. No significant relationship was observed between other sonographic findings with inflammatory markers and demographic factors.
Discussion
Takayasu’s arteritis is a rare disease that tends to present in young Asian woman (12) and considered as 6% of vasculitis cause in Iran (13). Vascular involvement is common and stroke occurs approximately 10 % in course of disease (14). In this study, the ratio of female to male was 4:1. We evaluated the carotid sonographic features in TAK when compared with DM as one of the most common cause of atherosclerosis (4). Also, we assessed the traditional risk factors of atherosclerosis, available serum level of metabolic and inflammatory biomarkers. Relation between systemic inflammation and atherosclerosis reported previously (5, 8, 11). Carotid artery plaques have been reported in one third of the patients with TAK (11). In our study, unilateral complete occlusion of carotid observed in 3 (20%) patients with TAK that they had history of stroke. (Complete occlusion of Lt CCA in 2, Rt CCA in 1,). Nevertheless, prevalence of atherosclerotic plaque was 46.7% in TAK and 53.3% in DM. It was almost similar to the results of other studies (8, 11).
Seyahi et.al reported carotid artery plaque in 27% patients with Takayasu arteritis, 18% patients with systemic lupus erythematous (SLE), and in 2% controls(5). Earliest finding of arteritis in sonography is wall thickening. First cases described by ultrasound reported the, homogeneous, circumferential vessel wall thickening in the proximal common carotid artery, had been causing a long segment of narrowing of the lumen in TAK (15-17) that is different from atherosclerosis (18). In studies, increase in intima-media thickness of carotid arteries in TAK reported (5, 10, 11, 19). We measured the IMT in multilevel such as; before bifurcation of both CCAs and after bifurcation of both ICAs, and reported with details that never reported in this format. IMT increased significantly in multi-levels of carotid arteries where our measurements performed in TAK patients compared to diabetic ones (table 3). In TAK group, the greatest IMT depicted before bifurcation of Lt CCA. (Before bifurcation Lt CCA IMT 1.41±0.98 mm in TAK, 0.63±0.17 mm in DM). We detected more increased IMT of carotid arteries in TAK, compared to other study. In the TAK group, the highest observed IMT was 1.41±0.98 mm and 1.35±0.87 mm a in the order before bifurcation Lt CCA and Rt CCA (P=0.015, P=0.005). Finally, the mean IMT of these four levels that measured was 1.1±0.71 mm.
An IMT < 0.7 mm is normal and 0.7 mm < IMT > 1.5 mm interpret as a thickened intima (10) media. In some studies, evaluation of carotid arteries has shown increased IMT in TAK, but in our study mean IMT that measured in TAK group is higher than other studies (5, 10, 11). First time, Seyahi et al. evaluated carotid arteries in TAK and systemic lupus erythematous (SLE). They reported increased of carotid arteries IMT in TAK (0.95±0.31 mm). There was no difference between IMT of SLE and healthy control (0.58±0.10 mm in SLE and 0.59±0.08 mm in controls) (5). In one study, IMT was more in DM group. IMT was reported 0.90± 0.36 mm in TAK, 0.96±0.25 in DM 0.40±0.12 mm and, 0.40±0.12 mm in healthy control by Serdal et al. that is different from our result (11).
IMT of carotid arteries in TAK compared to rheumatoid arthritis, showed , IMT of 0.91 mm±0.36 in TAK, 0.76 mm±0.15 in RA and 0.71±0.14 mm in control consecutively (8). Mean age of our patients with TAK was 35.20±8.85 with disease duration 7.73±5.56 years, that was similar to other studies in demographics however, these factors do not seem to be the cause of the difference in IMT (5, 8). In addition to the increased IMT in sonography of TAK, the presence of macaroni sign and turbulence can be seen in affected patients that are specific for TAK. Diffuse and homogeneous intima–media thickening >1 mm, in 76 % of patients with TAK and the absence of this finding in patients with SLE or the control group by Seyahi et al. had defined as sonographic finding suggestive for involvement with Takayasu arteritis (5). Also, Serdal et al. reported macaroni sign in 78% in TAK, 2% DM and Turbulence in 14% of TAK(11). Notably, in our patient with TAK, macaroni sign was seen of 60% patients(P=0.001) and turbulent flow (P=0.006) was seen of 46% patients and, these finding did not detect in DM. Additionally, among patients with TAK, increased resistive index was detected(P=0.047). It was 0.79± 0.17 in Lt CCA that was higher when compared with measured amounts RI that reported previously (11).Thus, patients can develop this feature during course of disease.
Metabolic syndrome in 14 to 62.8% of patients with autoimmune disorders had been observed. Also, atherosclerosis in patients with rheumatic diseases, reported(4). Some studies, however, have suggested an association between atherosclerosis and traditional atherosclerotic risk factors in TAK (12) but in our study patients with DM showed more CVD risk factors including HTN on physical exam (P= 0.042), higher BMI (P=0036) and greater level of FBS, cholesterol, LDL, triglyceride, AST, ALT, ALKP and less Cr levels (p<0.05), despite equivalent atherosclerosis rate and lower IMT compared with TAK. On the other side, CVD was higher in TAK group. ESR, CRP were higher in TAK however analysis cannot declare this fact, perhaps due to the small size of a sample because of the rarity of TAK. That seems the inflammation has a core stone of CVD in TAK. We interpret that whatever is important increasing IMT in Tak is not traditional CVD risk factor. To our knowledge, no reliable serological marker for TAK course has been described. However, ESR and CRP are commonly used to monitor disease activity in TAK but cannot distinct TAK progression always (20).
ESR has a sensitivity of 72% and specificity of 56% for active TAK, while CRP has a sensitivity of 71.4% and specificity up to 100% (6, 21). However, TAK can persist in the normal ESR and CRP (21). Also, fibrinogen is an acute-phase protein, a well-known marker of inflammation (7) that we assessed in this study, is higher in people with cardiovascular system diseases(22, 23) and never evaluated before in TAK. Although the serum level of ESR, CRP and fibrinogen was higher in patients with TAK than in DM, the difference was not statistically significant (p>0.05). On the other side, CBC seem to be simple and clear to show inflammation is better than ESR, CRP when compared in two group. WBC and platelet amounts were higher (P=0.039, P=0.042) and hemoglobulin (P=0.043) was lower in the TAK group. We detected the correlation of CRP and before bifurcation right CCA IMT (P= 0.051) also, correlation of ESR (P= 0.017) and CRP (P= 0.011) with before bifurcation left CCA IMT. A study on RA and TAK reported that CRP > 12 mg is strongly associated with accelerated atherosclerosis development (13).
As well another study evaluation of carotid IMT in patients with RA showed that CRP is correlated with the degree of preclinical atherosclerosis (9).Additionally, we showed the correlation between ESR with CRP (p-<0.001), with a coefficient correlation of 0.920 but no correlation between fibrinogen and ESR, or CRP detected. Interestingly, our findings showed that, for each unit increase in CPR, the value of before bifurcation right CCA mean IMT increases by 0.02 and this increase was statistically significant after adjusting for age, CVD, and HTN (P=0.05) that was never reported previously. Also, TAK patients had an average of 0.6 more before bifurcation right CCA mean IMT than DM patients (P=0.07) which was borderline significant. In other words, according to other studies (8, 9), we showed that what is related to the increase in the thickness of the intima-media is a higher CRP.
Our study like other studies of Takayasu arthritis has limited sample sizes due to the rarity of the disease, and heterogenous disease with varying clinical presentation making it difficult to achieve statistically significant results. So, a meta-analysis by combining data from multiple studies can increase the statistical power of analysis and provide a more reliable and precise estimate of the effect of sonography in Takayasu arthritis studies. Carotid sonography can be valuable in the management of Takayasu arteritis. Our study showed the parameters that can differentiate TAK from other causes of atherosclerosis including; the presence of macaroni sign, turbulence, and higher IMT and resistivity index and interestingly what is associated with increased intima–media thickness is higher CRP.
Acknowledgments
The authors would like to thank the Clinical Research Development Unit (CRDU) of Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences Tehran, Iran, for their support throughout the study.
Funding:
No grant numbers.
Ethics approval:
The Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran, has approved this study (IR.SBMU.RETECH.REC.1401.553).
Conflict of interests:
We declare no conflicts of interest.
Authors’ contribution:
Maryam Haghighi-Morad and Reza Rezaei: contributed equally; Resources, Validation. Muhanna Kazempour: Conceptualization, Methodology, Validation, Investigation, Data Curation, Writing - Original Draft, Writing - Review & Editing, Project administration, funding acquisition. Mohammad Mehdi Emam: Resources, Validation. Arezoo Ranjbar Arani: Resources, Validation. Mahbobeh Taheri: Formal analysis. Parisa Delkash: Resources, Validation.
References
- 1.Cicco S, Desantis V, Vacca A, et al. Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: A clinical, ex vivo and in vitro analysis. Front Med. 2022;9:863150. doi: 10.3389/fmed.2022.863150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Mason JC. Takayasu arteritis—advances in diagnosis and management. Nat Rev Rheumatol. 2010;6:406–15. doi: 10.1038/nrrheum.2010.82. [DOI] [PubMed] [Google Scholar]
- 3.Johnston S, Lock R, Gompels M. Takayasu arteritis: a review. J Clin Pathol. 2002;55:481–6. doi: 10.1136/jcp.55.7.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Surma S, Czober T, Lepich T, Sierka O, Bajor G. Selected biomarkers of atherosclerosis-clinical aspects. Acta Angiol. 2020;26:28–39. [Google Scholar]
- 5.Seyahi E, Ugurlu S, Cumali R, et al. Atherosclerosis in Takayasu arteritis. Ann Rheum Dis. 2006;65:1202–7. doi: 10.1136/ard.2005.047498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919–29. doi: 10.7326/0003-4819-120-11-199406010-00004. [DOI] [PubMed] [Google Scholar]
- 7.Hsieh C-T, Chien K-L, Hsu H-C, et al. Associations between fibrinogen levels and the risk of cardiovascular disease and all-cause death: a cohort study from the Chin-Shan community in Taiwan. BMJ Open. 2022;12:e054638. doi: 10.1136/bmjopen-2021-054638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Touboul P-J, Hennerici M, Meairs S, et al. Mannheim carotid intima-media thickness consensus (2004-2006) An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23:75–80. doi: 10.1159/000097034. [DOI] [PubMed] [Google Scholar]
- 9.Seyahi E, Esatoglu SN, Ugurlu S, et al. Can we differentiate Takayasus arteritis from atherosclerosis using carotid artery Doppler USG? Rheumatology. 2017;56:46–7. [Google Scholar]
- 10.Onen F, Akkoc N. Epidemiology of Takayasu arteritis. Presse Med. 2017;46:e197–203. doi: 10.1016/j.lpm.2017.05.034. [DOI] [PubMed] [Google Scholar]
- 11.Jokar M, Mirfeizi Z. Epidemiology of vasculitides in Khorasan province, Iran. Iran J Med Sci. 2015;40:362–6. [PMC free article] [PubMed] [Google Scholar]
- 12.Malek Mahdavi A, Rashtchizadeh N, Kavandi H, et al. Clinical characteristics and long-term outcome of Takayasu arteritisin Iran: a multicentre study. Turk J Med Sci. 2020;50:713–24. doi: 10.3906/sag-1910-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Ahmed H, Rachida G, Jean-Pierre L, et al. Accelerated atherosclerosis in Takayasu disease: Case-control study. Open J Intern Med. 2017;7:12–24. [Google Scholar]
- 14.Bond J, Charboneau J, Stanson A. Takayasu's arteritis Carotid duplex sonographic appearance, including color Doppler imaging. J Ultrasound Med. 1990;9:625–9. doi: 10.7863/jum.1990.9.11.625. [DOI] [PubMed] [Google Scholar]
- 15.Schmidt W, Nerenheim A, Seipelt E, Poehls C, Gromnica‐Ihle E. Diagnosis of early Takayasu arteritis with sonography. Rheumatology. 2002;41:496–502. doi: 10.1093/rheumatology/41.5.496. [DOI] [PubMed] [Google Scholar]
- 16.Chaubal N, Dighe M, Shah M. Sonographic and color Doppler findings in aortoarteritis (Takayasu arteritis) J Ultrasound Med. 2004;23:937–44. doi: 10.7863/jum.2004.23.7.937. [DOI] [PubMed] [Google Scholar]
- 17.Sun Y, Yip PK, Jeng JS, Hwang BS, Lin WH. Ultrasonographic study and long-term follow-up of Takayasu's arteritis. Stroke. 1996;27:2178–82. doi: 10.1161/01.str.27.12.2178. [DOI] [PubMed] [Google Scholar]
- 18.Park SH, Chung JW, Lee JW, Han MH, Park JH. Carotid artery involvement in Takayasu's arteritis: evaluation of the activity by ultrasonography. J Ultrasound Med. 2001;20:371–8. doi: 10.7863/jum.2001.20.4.371. [DOI] [PubMed] [Google Scholar]
- 19.O’Connor TE, Carpenter HE, Bidari S, Waters MF, Hedna VS. Role of inflammatory markers in Takayasu arteritis disease monitoring. BMC Neurol. 2014;14:1–9. doi: 10.1186/1471-2377-14-62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ishihara T, Haraguchi G, Tezuka D, et al. Diagnosis and assessment of Takayasu arteritis by multiple biomarkers. Circ J. 2013;77:477–83. doi: 10.1253/circj.cj-12-0131. [DOI] [PubMed] [Google Scholar]
- 21.Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb. 1992;12:780–8. doi: 10.1161/01.atv.12.7.780. [DOI] [PubMed] [Google Scholar]
- 22.Stec JJ, Silbershatz H, Tofler GH, et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation. 2000;102:1634–18. doi: 10.1161/01.cir.102.14.1634. [DOI] [PubMed] [Google Scholar]
